Much has been published on various aspects of data analysis and reporting from clinical trials within the biopharmaceutical environment. This ranges from regulatory guidelines on the format and content of registration dossiers to recommendations on data presentation and the statistical methodologies
A risk assessment framework for the reduction of cetacean by-catches
β Scribed by John Harwood
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 63 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1052-7613
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In this paper, the problem of company distress is assessed by means of a multiβperiod model that exploits the potentialities of the survival analysis approach when both survival times and regressors are measured at discrete points in time. The discreteβtime hazards model can be used bot
Targeting individuals with increased risk for common, chronic disease can improve the efficiency and efficacy of preventive efforts by improving the predictability of screening tests and participant compliance. Individuals with the greatest risk for these disorders are those with a genetic susceptib